Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
halaven
Synonyms :
Class :
Anti-neoplastic, anti-microbial
Brand Name :
halaven
Synonyms :
Class :
Anti-neoplastic, anti-microbial
Dosage Forms & StrengthsÂ
Intravenous solution:Â
1mg/2ml(0.5mg/ml)Â
IV: 1.4mg/m2 on days 1 to 8 of a 21-day cycle over 2-5 min
Liposarcoma metastatic:
IV: 1.4mg/m2 on days 1 to 8 of a 21-day cycle over 2-5 min
Dose Adjustments
Kidney impairment:
CrCl ≥50 mL/minute: No initial dosage adjustment is necessary
CrCl 15 to 49 mL/minute: Reduce initial dose to eribulin mesylate 1.1 mg/m2
Hepatic impairment:
Mild hepatic impairment: reduce initial dose to 1.1 mg/m2
Moderate hepatic impairment: reduce initial dose to 0.7 mg/m2
Severe hepatic impairment: No dosage adjustment provided in the US manufacturing list
Safety and efficacy not establishedÂ
Refer adult dosingÂ
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
QTc interval is increased both by lenvatinib and eribulin
when both drugs are combined, both increase the QTC interval   
both lapatinib and eribulin increase the QTc interval
eribulin and gilteritinib, when used in combination, increase the QTc interval
When eribulin is used together with adenosine, this leads to enhanced risk or seriousness of QTc prolongation
When eribulin is used together with andrographolide, this leads to enhanced risk or seriousness of bleeding
when both drugs are combined, there may be an increased risk or severity of adverse effects  
when both drugs are combined, there may be an increased risk or severity of adverse effects  
when both drugs are combined, there may be an increased risk or severity of QTC prolongation  
It may enhance the risk of adverse reactions when combined with Enzymes
Frequency defined:Â Â
>10%Â
Neutropenia (82%)Â
Anemia (58%)Â
Asthenia/fatigue (54%)Â
Alopecia (45%)Â
Peripheral neuropathy (35%)Â
Nausea (35%)Â
Constipation (25%)Â
Arthralgia/myalgia (22%)Â
Pyrexia (21%)Â
Weight loss (21%)Â
Anorexia (20%)Â
Headache (19%)Â
Vomiting (18%)Â
Diarrhea (18%)Â
Back pain (16%)Â
Dyspnea (16%)Â
Cough (14%)Â
Bone pain (12%)Â
Extremity pain (11%)Â
Urinary tract infection (10%)Â
1-10%Â
Increased lacrimationÂ
DyspepsiaÂ
Abdominal painÂ
StomatitisÂ
XerostomiaÂ
URIÂ
HypokalemiaÂ
Muscle spasm/weaknessÂ
DysgeusiaÂ
DizzinessÂ
InsomniaÂ
DepressionÂ
RashÂ
Post-marketing reports:Â
PancreatitisÂ
LymphopeniaÂ
HepatotoxicityÂ
Drug hypersensitivityÂ
PneumoniaÂ
PruritusÂ
Stevens-Johnson syndromeÂ
Â
No contraindications listed in the US manufacturing labelÂ
Pregnancy consideration: The drug may cause fetal harm when administeredÂ
Pregnancy category: DÂ
Lactation: The release of the drug in human breast milk is unknownÂ
Pregnancy category:Â
Patient information leafletÂ
Generic Name:eribulinÂ
Pronounced: [e-RIB-ue-lin]Â
Why do we use eribulin?Â
Eribulin is used to treat metastatic breast cancer in patients.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
